To comprehensively examine whether systemic CXCL10 levels could be used as a proxy for deterioration of lung function in SSc-ILD, we correlated serum CXCL10 in patients with SSc-ILD with %FVC predicted and %DLco predicted. The gene discussed is CXCL10; the disease is systemic sclerosis.